- Tytuł:
- Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Oncology June 2015 16(6):656-666
Czasopismo naukowe